73
Participants
Start Date
December 31, 2006
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
ziprasidone (Geodon)
ziprasidone, geodon. Dosing instructions began at 40 mg/day and were increased by increments of 20-40 mg weekly weekly based on target symptoms and tolerability with a target range of 80-160 mg/d of ziprasidone for 6 weeks.
placebo
Placebo, sugar pill arm. Dosing instructions began at 40 mg/day and were increased by increments of 20-40 mg weekly weekly based on target symptoms and tolerability with a target range of 80-160 mg/d of ziprasidone for 6 weeks.
Duke University, Durham
Northwestern University, Chicago
Tufts University, Boston
Cambridge Health Alliance, Cambridge
Collaborators (1)
Pfizer
INDUSTRY
Tufts Medical Center
OTHER